Tysabri Re-Launches In U.S. Through Single Distributor
This article was originally published in The Pink Sheet Daily
Executive Summary
Biogen Idec/Elan's multiple sclerosis therapy Tysabri is available in the U.S. through a single distributor: AmerisourceBergen Specialty Group division ICS
You may also be interested in...
Biogen Idec’s Reports Of Tysabri Side Effects Don’t Rattle FDA
Wall Street reacted sharply to disclosure of two new PML cases associated with Tysabri, but it doesn’t sound like FDA plans a regulatory response.
Biogen Idec’s Reports Of Tysabri Side Effects Don’t Rattle FDA
Wall Street reacted sharply to disclosure of two new PML cases associated with Tysabri, but it doesn’t sound like FDA plans a regulatory response.
Joint Panel Recommends Tysabri For Crohn’s Disease
The highly restricted Tysabri risk management program tipped the risk-benefit scale in Biogen Idec/Elan’s favor.